ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
61.102,82
0,51%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Molecular Insight Pharmaceuticals (MM) (MIPI)

  7. Molecular Insight Pharmaceuticals (MM) (MIPI) News

MIPI

Molecular Insight Pharmaceuticals (MM) (MIPI)

Molecular Insight Pharmaceuticals (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MIPI
DatumZeitQuelleÜberschriftSymbolFirma
21/12/201001h42MarketwiredMolecular Insight Announces NASDAQ Decision to Delist Common Stock and Transfer to OTCQB(TM) MarketplaceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/12/201017h18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/12/201022h39Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
10/12/201004h46MarketwiredMolecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management ChangesNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201012h02Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201001h38MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/11/201023h16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/11/201022h59MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201018h43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201015h31Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201013h21MarketwiredMolecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial and Operational ResultsNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/11/201022h28Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/11/201022h18MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/10/201023h06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/10/201022h49MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201022h51Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201022h30MarketwiredMolecular Insight Pharmaceuticals Data Indicate Trofex(TM) May Enable Visualization and Monitoring of Response to Prostate CanceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201022h01MarketwiredMolecular Insight Announces Resignation of Chief Medical OfficerNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
15/10/201023h30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
15/10/201023h13MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/10/201022h49MarketwiredMolecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for DetecNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
08/10/201014h00MarketwiredMolecular Insight Pharmaceuticals Receives NASDAQ Notification LettersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201018h05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201017h47MarketwiredMolecular Insight Receives Eleventh Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201020h58Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201020h51Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201017h16MarketwiredMolecular Insight Receives Tenth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201016h04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201014h00MarketwiredMolecular Insight Receives Ninth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
01/09/201021h38Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:MIPI

Kürzlich von Ihnen besucht

BIT
IVSAXA
IVS
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten